Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets.

Patel A, Tannock IF, Srivastava P, Biswas B, Gupta VG, Batra A, Bhethanabhotla S, Pramanik R, Mahindru S, Tilak T, Das CK, Mehta P.

Open source

DOI
10.1200/jgo.19.00341
Published
2020-03-01
Container
JCO Glob Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jgo.19.00341,
  title = {Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets.},
  author = {Patel A and  Tannock IF and  Srivastava P and  Biswas B and  Gupta VG and  Batra A and  Bhethanabhotla S and  Pramanik R and  Mahindru S and  Tilak T and  Das CK and  Mehta P.},
  year = {2020},
  journal = {JCO Glob Oncol},
  doi = {10.1200/jgo.19.00341},
  url = {https://doi.org/10.1200/jgo.19.00341}
}

RIS

TY  - JOUR
TI  - Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets.
AU  - Patel A
AU  -  Tannock IF
AU  -  Srivastava P
AU  -  Biswas B
AU  -  Gupta VG
AU  -  Batra A
AU  -  Bhethanabhotla S
AU  -  Pramanik R
AU  -  Mahindru S
AU  -  Tilak T
AU  -  Das CK
AU  -  Mehta P.
PY  - 2020
JO  - JCO Glob Oncol
DO  - 10.1200/jgo.19.00341
UR  - https://doi.org/10.1200/jgo.19.00341
ER  - 

APA

A, P., IF, T., P, S., B, B., VG, G., A, B., S, B., R, P., S, M., T, T., CK, D., & P., M. (2020). Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets.. JCO Glob Oncol. https://doi.org/10.1200/jgo.19.00341

Source records